Monoclonal Antibody: Mouse anti-human beta2-adrenergic receptor

Scientists at the Georg-August-University generated monoclonal antibodies which specifically react with beta2-adrenergic receptor (b2AR) on human leukocytes and other cells with physiological expression levels of this receptor. b2AR is a prototypic G protein coupled receptor which is activated by catecholamines. It fulfills important roles in the regulation of several organ systems and coordinates functions of the endocrine, neurological and immune system. b2AR mediate glycogenolysis/gluconeogenesis in liver and relaxation of smooth muscle and are important drug targets for a wide variety of cardiovascular, respiratory and other deseases.

Further Information: PDF

MBM ScienceBridge GmbH
Phone: (0551) 30724-151

Contact
Dr. Jens-Peter Horst

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All news from this category: Technology Offerings

Back to the Homepage

Comments (0)

Write comment

Latest posts

Bringing atoms to a standstill: NIST miniaturizes laser cooling

It’s cool to be small. Scientists at the National Institute of Standards and Technology (NIST) have miniaturized the optical components required to cool atoms down to a few thousandths of…

Record-breaking laser link could help us test whether Einstein was right

Scientists from the International Centre for Radio Astronomy Research (ICRAR) and The University of Western Australia (UWA) have set a world record for the most stable transmission of a laser signal through…

Adaptive optics with cascading corrective elements

A cascaded dual deformable phase plate wavefront modulator enables direct AO integration with existing microscopes–doubling the aberration correction range and greatly improving image quality. Microscopy is the workhorse of contemporary…

Partners & Sponsors

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close